Case Study Rapid, Transparent Evaluation Helps ‘Stuck’ Biotech Board Resolve Debate over Promising Cancer Therapy
Case Study Cutting-edge Prioritization Model Enables Consistent Evaluation of Early-stage Drugs Across Pharma Portfolio
Case Study Pharmaceutical Company Requires Nimble Development Strategy When Faced with Unforeseen Challenges